CTI Molecular Imaging Inc. in August acquired all the capital stock of Mirada Solutions Ltd., a developer of fusion software applications for medical imaging workstations, for approximately $22 million.
Miranda shareholders also may receive additional compensation based on its future financial results.
The positron emission tomography (PET) developer and manufacturer plans to incorporate Mirada's image analysis and fusion software into all its PET scanner workstations to enhance analytical and diagnostic features. Mirada's software is designed to detect, diagnose and manage disease through image analysis tools.
The acquisition also prompts CTI to take a one-time, non-cash pretax charge of approximately $1.3 million to write off Miranda's in-process research-and-development expenses.